Other safety alerts
|
| |
| Australia: Continuing imports of counterfeit ivermectin |
| |
The Therapeutic Goods Administration (TGA) are continuing to see imports of counterfeit ivermectin, with recent testing following previously warnings in December 2021 and March 2022, regarding the importation of ivermectin and the risks associated with counterfeit therapeutic goods.
The TGA has tested a further 6 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989. Three of these were retested as they were previously found to be counterfeit with no changes in quality since. Laboratory analysis confirmed that the following products contain less than the stated 12mg of the active pharmaceutical ingredient, ivermectin: Iversun-12, Covimectin-12, Iverheal-12, Iverhuman-12, Ivetab-12 and Iverguard-12.
As with the previous warnings issued, these products were purchased online from an overseas website and were not bought from an Australian pharmacy. The TGA advises consumers to exercise extreme caution when purchasing medicines from unknown overseas websites and recommend obtaining them from an Australian pharmacy. Counterfeit products may contain undeclared and hazardous ingredients that could cause a serious adverse reaction. They may also be contaminated because of a lack of manufacturing and testing standards.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/news/safety-alerts/continuing-imports-counterfeit-ivermectin
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by TGA, and was posted on the Drug Office website on 14 Dec 2021 and 4 Mar 2022.
Ends/Monday, Oct 28, 2024
Issued at HKT 15:30
|
| |
|
